Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2000

Conditions
LeukemiaLymphoma
Interventions
DRUG

arsenic trioxide

Trial Locations (52)

3052

Royal Children's Hospital, Parkville

6001

Princess Margaret Hospital for Children, Perth

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10021

Memorial Sloan-Kettering Cancer Center, New York

10032

Herbert Irving Comprehensive Cancer Center at Columbia University, New York

13210

SUNY Upstate Medical University Hospital, Syracuse

15213

Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

27710

Duke Comprehensive Cancer Center, Durham

30342

AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus, Atlanta

48201

Children's Hospital of Michigan, Detroit

53226

Midwest Children's Cancer Center, Milwaukee

55905

Mayo Clinic Cancer Center, Rochester

60614

Children's Memorial Hospital - Chicago, Chicago

63104

Cardinal Glennon Children's Hospital, St Louis

63110

St. Louis Children's Hospital, St Louis

64108

Children's Mercy Hospital, Kansas City

72205

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock

73126

Oklahoma University Medical Center, Oklahoma City

76104

Cook Children's Medical Center - Fort Worth, Fort Worth

84112

Huntsman Cancer Institute at University of Utah, Salt Lake City

90509

County of Los Angeles Harbor-UCLA Medical Center, Torrance

92868

Children's Hospital of Orange County, Orange

94143

UCSF Comprehensive Cancer Center, San Francisco

94304

Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

92103-8447

Rebecca and John Moores UCSD Cancer Center, La Jolla

90027-0700

Children's Hospital Los Angeles, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

20010-2970

Children's National Medical Center, Washington D.C.

46202-5225

Riley Children Cancer Center at Riley Hospital for Children, Indianapolis

66160-7357

Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

02111

Floating Hospital for Children, Boston

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

48109-0914

University of Michigan Comprehensive Cancer Center, Ann Arbor

39216-4505

University of Mississippi Medical Center, Jackson

07601

Cancer Center at Hackensack University Medical Center, Hackensack

45229-2899

Cincinnati Children's Hospital Medical Center, Cincinnati

44106-5065

Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University, Cleveland

38105-2794

St. Jude Children's Research Hospital, Memphis

37232-6310

Vanderbilt Children's Hospital, Nashville

75390-9063

Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

77030-2399

Texas Children's Cancer Center, Houston

77030-4009

MD Anderson Cancer Center at University of Texas, Houston

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

M5G 1X8

Hospital for Sick Children, Toronto

H3H 1P3

Montreal Children's Hospital at McGill University Health Center, Montreal

H3T 1C5

Hopital Sainte Justine, Montreal

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00020111 - Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma | Biotech Hunter | Biotech Hunter